Do you want to read an article? Please log in or register.
Early clinical pharmacology evaluation of the novel anti-inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactions
COPD
Related content
RECOMMENDED
Tuberculosis
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Saukkonen JJ, Duarte R, Munsiff SS, Winston CA, Mammen MJ, Abubakar I, Acuña-Villaorduña C, Barry PM, Bastos ML, Carr W, Chami H, Chen LL, Chorba T, Daley CL, Garcia-Prats AJ, Holland K, Konstantinidis I, Lipman M, Battista Migliori G, Parvez FM, Shapiro AE, Sotgiu G, Starke JR, Starks AM, Thakore S, Wang SH, Wortham JM, Nahid P
doi: 10.1164/rccm.202410-2096ST
Asthma
Challenges in Evaluating Clinical Remission in Severe Asthma: Insights from the Mayo Clinic
Adv Ther
Lim K, Deb A, Corbridge T, Lee L, Kelloway J, Simsek S, Manoharan M, Barman H, Wagner T
doi: 10.1007/s12325-025-03433-y
Tuberculosis
Effectiveness and Implementation of A Clinical Risk Score for Early Diagnosis of Tuberculosis in Uganda: A Pragmatic, Clustered Randomization Clinical Trial
Ann Am Thorac Soc
Baik Y, Musoke M, Twinamasiko A, Lamunu M, Nabacwa V, Sanyu A, Robsky KO, Sung J, Kityamuwesi A, Katamba A, Dowdy DW
doi: 10.1513/AnnalsATS.202404-422OC
RECOMMENDED
Pulmonary FibrosisBronchi
Efficacy of Anti-Inflammatory Therapies for Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and Network Meta-Analysis
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Yamamoto S, Niitsu T, Fukushima K, Shiozawa A, Imai R, Hashimoto K, Olivier KN, Aksamit TR, Morimoto K
doi: 10.1016/j.chest.2025.12.035
RECOMMENDED
Pleural Diseases
Optimising response to immunotherapies in pleural mesothelioma: clinical data and alternative models for the evaluation of new strategies
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Thorax
Blanquart C, Scherpereel A
doi: 10.1136/thorax-2025-223284
RECOMMENDED
Further Publications
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med
Durieu I, Clements B, Fabrizzi B, Mall MA, McKone E, Ramsey B, Tullis E, Taylor-Cousar JL, van der Meer R, Bachman E, Chin A, Conner S, Jennings M, Weinstock T, Colombo C, Robinson P
doi: 10.1164/rccm.202411-2312OC
Further Publications
Patient Factors and Clinical Efficacy of Early Identification and Treatment of COPD and Asthma
Am J Respir Crit Care Med
Tardif A, Whitmore GA, Vandemheen KL, Bergeron C, Boulet LP, Côté A, McIvor RA, Penz E, Field SK, Lemière C, Mayers I, Bhutani M, Azher T, Lougheed MD, Gupta S, Ezer N, Licskai CJ, Hernandez P, Ainslie M, Alvarez GG, Mulpuru S, Aaron SD
doi: 10.1164/rccm.202505-1260OC
Asthma
Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study
J Clin Med
Ausín P, Navarrete-Rouco ME, Carazo L, Sanchez-Trincado JL, Luzon E, Nuevo J, Santín M, Sánchez J, Padilla-Galo A
doi: 10.3390/jcm14093011
RECOMMENDED
COPD
Inflammatory Response in Exacerbations of COPD: Clinical and Predictive Roles of C-Reactive Protein
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Semin Respir Crit Care Med
Sartori G, Fantin A, Sartori F, Crisafulli E
doi: 10.1055/a-2818-1526